Effects of human interferons and 60Cobalt radiation on canine and feline tumour cells - Preclinical studies;Human-interferon und 60Kobalt-bestrahlung bei tumorzellen des hundes und der Katze - Präklinische studien

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 43, Issue 10, 1996, Pages 599-609

  Kessler, M ^a,b   Hammer, A S ^a   Bailey, M Q ^a   Tempel, K H ^b   Matis, U ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; FELIDAE;

COBALT; INTERFERON; RECOMBINANT PROTEIN;

ADENOCARCINOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; CELL DIVISION; DOG; DOG DISEASE; DOSE RESPONSE; DRUG EFFECT; HUMAN; MELANOMA; MULTIMODALITY CANCER THERAPY; NEOPLASM; OSTEOSARCOMA; PATHOLOGY; PHYSIOLOGY; RADIATION DOSE; RADIATION RESPONSE; RADIOTHERAPY; SENSITIVITY AND SPECIFICITY; STANDARD; SURVIVAL RATE;

ADENOCARCINOMA; ANIMALS; CAT DISEASES; CATS; CELL DIVISION; COBALT RADIOISOTOPES; COMBINED MODALITY THERAPY; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; INTERFERONS; MELANOMA; NEOPLASMS; OSTEOSARCOMA; RADIATION TOLERANCE; RADIOTHERAPY; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 2842540251     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0442.1996.tb00493.x     Document Type: Article

References (45)

1. ADAMS, D. O., und T. A. HAMILTON, 1987: Molecular transductional mechanisms by which IFN-gamma and other signals regulate macrophage development. Immunol. Rev. 97, 5-27.
2. BORDEN, E. C., T. F. HOGAN, and J. G. VOELKEL, 1982: Comparative antiproliferative activity in vitro of natural interferons α und β for diploid and transformed human cells. Cancer Res. 42, 4948-4953.
3. BRIDGMAN, R., C. R. ROSSI, and M. CAMPOS, 1988: The sensitivity of domestic animal cell lines to eight recombinant human interferons. J. Interferon Res. 8, 1-4.
4. BRONSON, R. T., 1982: Variation in age at death of dogs of different sexes and breeds. Am. J. Vet. Res. 43, 2057-2059.
5. CARMICHAEL, J., W. G. DEGRAFF, A. F. GAZDAR, and J. B. MITCHELL, 1987a: Evaluation of a tetrazolium based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47, 936-942.
6. CARMICHAEL, J., W. G. DEGRAFF, A. F. GAZDAR, and J. B. MITCHELL, 1987b: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res. 47, 943-946.
7. 2-M Phase of the cell cycle. Cancer Res. 47, 4338-4341.
8. CHANG, A. Y. C., P. C. KENG, and J. BENNET, 1985: Enhanced cytotoxicity of irradiation (XRT) by human recombinant interferon αD. Proc. Am. Assoc. Cancer Res. 26, 324 (Abstr.).
9. DENZ, H., M. LECHLEITNER, CH. MARTH, G. DAXENBICHLER, G. GASTL, and H. BRAUNSTEINER, 1985: Effect of human recombinant alpha-2- and gamma-interferon on the growth of human cell lines from solid tumors and hematologic malignancies. J. Interferon Res. 5, 147-157.
10. DEVITA, V. T., S. HELLMAN, and S. A. ROSENBERG, 1992: Biologic Therapy of Cancer. J. B. Lippincott Co., Philadelphia, PA.
11. DRITSCHILO, A., K. MOSSMAN, M. GRAY, and T. SREEVALSAN, 1982: Potentiation of radiation injury by interferon. Am. J. Clin. Oncol. (CCT) 5, 79-82.
12. FERTIL, B., und E. P. MALAISE, 1981: Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 7, 621-629.
13. FRIEDMAN, R. L., S. P. MANLY, M. MCMAHON, I. M. KERR, and G. M. STARK, 1984: Transcriptional and posttranscriptional regulation of interferon induced gene expression in human cells. Cell 38, 745-755.
14. FU, K. K. 1985: Biological basis for the interaction of chemotherapeutic agents and radiation therapy. Cancer 55, 2123-2130.
15. GIBSON, D. M., S. COTLER, H. E. SPIEGEL, and W. A. COLBURN, 1985: Pharmacokinetics of recombinant Leukocyte A interferon following various routes and modes of administration in the dog. J. Interferon Res. 5, 403-408.
16. GILLETTE, E. L., 1982: Spontaneous canine neoplasms as models for therapeutic agents. In: FIDLER, I. J., und R. J. WHITE (Hrsg.), Design of Models for Testing Cancer Therapeutic Agents. Van Nostrand Reinhold Co, New York. S. 185-192.
17. GOULD, M. N., R. C. KAKRIA, S. OLSON, and E. C. BORDEN, 1984: Radiosensitization of human bronchogenic carcinoma cells by interferon beta. J. Interferon Res. 4, 123-128.
18. HAMMER, A. S., and C. G. COUTO, 1996: Phase I and II clinical trial of Hu rIFN α 2b in canine malignant melanoma and cutaneous lymphoma. Ohio Veterinary Cooperative Oncology Group (in press).
19. HANSEN, M. B., S. E. NIELSEN, and K. BERG, 1989: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119, 203-210.
20. HOLSTI, L. R., K. MATTSON, A. NIIRANEN, C. G. STANDERTSKIOLD-NORDENSTAM, S. STENMAN, A. SOVIJARVI, and K. CANTELL, 1987: Enhancement of radiation effects by alpha interferon in the treatment of small cell carcinoma of the lung. Int. J. Radiat. Oncol. Biol. Phys. 13, 1161-1166.
21. KASZA, L., 1964: Establishment and characterization of canine thyroid adenocarcinoma and canine melanoma cell lines. Am. J. Vet. Res. 25, 1178-1186.
22. 60Cobalt-Bestrahlungen und Human-Interferon α und γ bei Tumorzellen des Hundes und der Katze. Diss. Med. Vet., München.
23. KESSLER, M., A. S. HAMMER, and M. Q. BAILEY, 1993: Use of the Tetrazolium-Formazan (MTT)-assay in detecting radiation induced cell kill. Proc. 11th Annual Veterinary Medical Forum ACVIM, San Francisco (Abstr.).
24. KIRKWOOD, J. M., and M. ERNSTOFF, 1986: Potential applications of the interferons in oncology: lessons drawn from studies of human melanoma. Semin. Oncol. 13, (supp. 2), 48-56.
25. KURZROCK, R., und M. TALPAZ, 1992: Interferons- α, β, γ: Basic principles and preclinical studies. In: DEVITA, V. T., S. HELLMAN, and S. A. ROSENBERG (eds), Biologic Therapy of Cancer. J. B. Lippincott Co., Philadelphia, PA. pp. 259-262.
26. KYLE, G., P. WOOLLEY, S. KUMAR, and K. MOSSMAN, 1985: Antiproliferative effects of human recombinant interferon in combination with radiation and chemotherapeutic drugs in five human cell lines. Proc. Assoc. Cancer Res. 26, 327 (Abstr. 1288).
27. MAASILTA, P., L. R. HOLST, and K. MATTSON, 1990: Alpha-interferon in conjugation with radiotherapy in the treatment of non-small cell lung cancer. A pilot study. ISIR Meeting on the Interferon System 10 (suppl. 1), 129 (Abstr. II 6-25).
28. MACEWEN, E. G., I. D. KURZMAN, and R. C. ROSENTHAL, 1991: Combined liposome-encapsulated muramyl tripeptide and cisplatin in dogs with osteosarcoma. Abstract. Proc. 13th Ann. Conf., Veterinary Cancer Society, Minneapolis, MN. p. 24.
29. MACEWEN, E. G., I. D. KURZMAN, S. HELFAND, D. VAIL, and E. KELLER, 1993: Combined liposome-MTP-PE and rcG-CSF as therapy for canine osteosarcoma: a randomized study. Proc. 13th Ann. Conf. Veterinary Cancer Society, Columbus, OH. p. 70 (Abstr.).
30. MAULDIN, G. N., und K. A. MELEO, 1995: Radiation therapy: principles and clinical applications. In: ETTINGER, S. J., and E. C. FELDMAN (eds), Textbook of Veterinary Internal Medicine. W. B. Saunders Co., Philadelphia, PA. pp. 494-506.
31. MOSMANN, T., 1983: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65, 55-63.
32. MURRAY, H. W., 1988: Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann. Intern. Med. 108, 595-608.
33. NAMBA, M., S. YAMAMOTO, H. TANAKA, T. KANAMORI, M. NOBUHARA, and T. KIMOTO, 1984: In vitro and in vivo studies of potentiation of cytotoxic effects of anticancer drugs or Cobalt-60 gamma ray by interferon on human neoplastic cells. Cancer 54, 2262-2267.
34. NEDERMAN, T., and G. BENEDIKTSSON, 1982: Effects of interferon on growth rate and radiation sensitivity of cultured human glioma cells. Acta Radiol. Oncol. 21, 231-234.
35. QUESADA, J. R., and J. U. GUTTERMAN, 1987: Interferons in the treatment of human neoplasms. J. Interferon Res. 7, 575-581.
36. RIGGS, J. L., R. M. MCALLISTER, and E. H. LENNETTE, 1974: Immunofluorescent studies of RD-114 virus replication in cell culture, J. Gen. Virol. 25, 21-29.
37. ROJKO, J. L., G. C. KOCIBA, K. L. ABKOWITZ, K. L. HAMILTON, W. D. HARDY, J. N. IHLE, and S. J. O'BRIEN, 1989: Feline lymphomas; immunological and cytochemical characterization. Cancer Res. 49, 345-351.
38. ROSNER, B., 1990: Fundamentals of Biostatistics. Ch. 12: Analysis of Variance. 3. Aufl. PWS Kent Publishing Co., Boston, MA. pp. 474-526.
39. SINCLAIR, W. K., und R. A. MORTON, 1966: X-ray sensitivity during the cell generation cycle of cultured chinese hamster cells. Radiat. Res. 29, 450-474.
40. SPIEGEL, R. J., 1985: Intron A (Interferon alpha 2b): Clinical overview. Cancer Treat. Rev. 12 (suppl B), 5-16.
41. SUTER, M. M., D. M. PANTANO, J. A. FLANDERS, H. G. AUGUSTIN-VOSS, E. P. DOUGHERTY, and M. VARVAYANIS, 1991: Comparison of growth and differentiation of normal and neoplastic canine keratinocyte cultures. Vet. Pathol. 28, 131-138.
42. THRALL, D. E., and M. W. DEWHIRST, 1989a: Radiation Therapy. In: WITHROW, S. J., and E. G. MACEWEN (eds), Clinical Veterinary Oncology. Lippincott, Philadelphia, PA. pp. 84-85.
43. THRALL, D. E., D. A. MCLEOD, G. C. BENTEL, and M. W. DEWHIRST, 1989b: A review of treatment planning and dose calculation in veterinary radiation oncology. Vet. Radiol. 30, 194-221.
44. TORRISI, J., C. BERG, E. BONNEM, and A. DRITSCHILO, 1986: The combined use of interferon and radiotherapy in cancer management. Semin. Oncol. 13 (suppl. 2), 78-83.
45. TWENTYMAN, P. R., and M. LUSCOMBE, 1987: A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br. J. Cancer 56, 279-285.